MAIA Biotechnology Q4 EPS $(0.08) Beats $(0.13) Estimate

MAIA Biotechnology reported a Q4 EPS of $(0.08), surpassing the analyst consensus estimate of $(0.13) by 38.46%. This represents a 33.33% improvement compared to losses of $(0.12) per share in the same quarter last year.